New Technology Benefits Liver Transplants

Translate to Spanish or other 102 languages!

hen it comes to organ donations, every second counts, and that’s why Cleveland Clinic surgeons are using new technology to help preserve livers before they’re transplanted. Image for illustration purposes
hen it comes to organ donations, every second counts, and that’s why Cleveland Clinic surgeons are using new technology to help preserve livers before they’re transplanted. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – When it comes to organ donations, every second counts, and that’s why Cleveland Clinic surgeons are using new technology to help preserve livers before they’re transplanted. 

“Many have seen the ice coolers that we use to store the organ between the donor and the recipient. And when we get back to the transplant center, we take the organ off of ice and do the transplant, but ice storage is not the healthiest way of sustaining an organ that’s going to be transplanted,” explained David Reich, MD, surgical director of the liver transplant program for Cleveland Clinic Florida. “And so, the new machine perfusion technologies that we have keep the organ somewhat alive between the donor and the recipient.” 

Image Source: Gwilz, CC BY-SA 4.0 <https://creativecommons.org/licenses/by-sa/4.0>, via Wikimedia Commons

- Advertisement -

Dr. Reich said by using perfusion methods, they’re able to pump oxygenated blood or solution through a donor’s liver outside the body. 

That in turn can help improve the quality of the organ. 

It also gives surgeons a chance to better examine the liver and determine if it’s healthy enough to be transplanted, or they can further rejuvenate the liver. 

Research shows perfusion has helped reduce the risk for complications as well. 

- Advertisement -

“We have better results when we use perfusion. Patients go home from the hospital sooner, they have fewer complications, they have better safety in the operating room during the transplants, and then during their post-operative and longer-term course,” Dr. Reich noted.

 Dr. Reich said research continues on the use of this new technology, but it’s already showing a lot of promise and is starting to be used for other types of organ transplants. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -